Drug Trial Radar · NCT02193620
Study of PHN131 in Patients After Surgery
Last checked: Nov 20, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
106
Actual
Start
Apr 30, 2013
Primary completion
Sep 21, 2014
Study completion Feb 13, 2019
Sponsor
- Lead sponsor
- PhytoHealth CorporationIndustry
- Sponsor type
- Industry
- First posted
- Jul 17, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effectiveness, safety and pharmacokinetics of Oral Nalbuphine in the treatment of postoperative pain following hemorrhoidectomy.
Conditions
- Analgesia Disorder
Interventions
PHN131 soft capsule with Nalbuphine HCl 60 mg/capDrug
Multiple dose of oral PHN131 soft capsule with Nalbuphine HCl 60 mg/cap, initial dose : 120 mg ( 2 capsules), then 60 mg (1 capsule); t.i.d.
Placebo soft capsulesDrug
Multiple dose of oral Placebo soft capsules, initial dose: 2 capsules, then 1 capsule; t.i.d.
DiclofenacDrug
All subjects will receive diclofenac by IM injection for analgesia as rescue pain control.
Primary outcomes
What the sponsor says the trial is designed to measure.
- the area under the curve of Visual Analogue Scale (VAS) pain intensity scoresTime frame: at 1, 2, 3, 4±0.25, 8±0.5, 12±0.5, 16±0.5, 20±0.5, 24±1, 28±1, 32±2, 36±2, 40±2, 44±2, and 48±2 h after the surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
General Clinical Research Center, Tri-service General Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.